Tag: Immunome

Despite the disruptions caused by the coronavirus pandemic and labor shortages, Philadelphia experienced a venture capital boom in 2021, write Taylor Allen and Mike D…

Exton

With Omicron Variant Now in the U.S., Could Exton-Based Immunome’s ‘Antibody Cocktail’ Be the Neutralizer?

December 3, 2021

Exton-based Immunome has submitted an application with the FDA to start human testing its “antibody cocktail” as a potential COVID-19 treatment, writes John…

Tag: Immunome

Neither the Pandemic Nor Labor Shortages Could Mute Phila.'s 2021 Venture Capital Boom

With Omicron Variant Now in the U.S., Could Exton-Based Immunome’s ‘Antibody Cocktail’ Be the Neutralizer?